RPGLIFE

RPG Life Sciences Share Price

₹2,119.60 -21.55 (-1.01%)

28 Dec, 2024 01:04

SIP TrendupStart SIP in RPGLIFE

Start SIP

Performance

  • Low
  • ₹2,105
  • High
  • ₹2,159
  • 52 Week Low
  • ₹1,307
  • 52 Week High
  • ₹2,975
  • Open Price₹2,141
  • Previous Close₹2,141
  • Volume6,915

Investment Returns

  • Over 1 Month + 4.43%
  • Over 3 Month -5.97%
  • Over 6 Month + 29.68%
  • Over 1 Year + 54.82%
SIP Lightning

Smart Investing Starts Here Start SIP with RPG Life Sciences for Steady Growth!

Invest Now

RPG Life Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 49.6
  • PEG Ratio
  • -5.7
  • Market Cap Cr
  • 3,506
  • P/B Ratio
  • 9.4
  • Average True Range
  • 89.34
  • EPS
  • 52.65
  • Dividend Yield
  • 0.8
  • MACD Signal
  • -27.25
  • RSI
  • 38.76
  • MFI
  • 56.56

RPG Life Sciences Financials

RPG Life Sciences Technicals

EMA & SMA

Current Price
₹2,119.60
-21.55 (-1.01%)
pointer
  • stock-down_img
  • Bullish Moving Average 3
  • stock-up_img
  • Bearish Moving Average 13
  • 20 Day
  • ₹2,211.17
  • 50 Day
  • ₹2,261.31
  • 100 Day
  • ₹2,206.80
  • 200 Day
  • ₹2,006.34

Resistance and Support

2127.92 Pivot Speed
  • R3 2,204.98
  • R2 2,182.07
  • R1 2,150.83
  • S1 2,096.68
  • S2 2,073.77
  • S3 2,042.53

What's your outlook on RPG Life Sciences?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

RPG Life Sciences Ltd. is a prominent pharmaceutical company in India, specializing in the development, manufacturing, and marketing of generic formulations, active pharmaceutical ingredients (APIs), and contract research services. The company focuses on quality and innovation across therapeutic segments.

R P G Life Sciences has an operating revenue of Rs. 618.32 Cr. on a trailing 12-month basis. An annual revenue growth of 14% is good, Pre-tax margin of 20% is great, ROE of 23% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is trading below to its 50DMA and around 12% up from its 200DMA. It needs to take out the 50DMA levels and stay above it to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 62 which is a FAIR score but needs to improve its earnings, a RS Rating of 67 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 57 indicates it belongs to a fair industry group of Medical-Diversified and a Master Score of C is fair but needs to improve. Institutional holding has gone up in the last reported quarter is a positive sign. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

RPG Life Sciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-07 Quarterly Results
2024-07-19 Quarterly Results
2024-04-30 Audited Results & Final Dividend
2024-02-01 Quarterly Results
2023-10-18 Quarterly Results
Date Purpose Remarks
2024-06-28 FINAL Rs.16.00 per share(200%)Final Dividend
2023-07-21 FINAL Rs.12.00 per share(150%)Final Dividend
2022-07-15 FINAL Rs.9.60 per share(120%)Final Dividend
2021-08-17 FINAL Rs.7.20 per share(90%)Dividend

RPG Life Sciences F&O

RPG Life Sciences Shareholding Pattern

72.81%
2.67%
0.39%
1.35%
0.01%
15.92%
6.85%

About RPG Life Sciences

  • NSE Symbol
  • RPGLIFE
  • BSE Symbol
  • 532983
  • Managing Director
  • Mr. Yugal Sikri
  • ISIN
  • INE105J01010

Similar Stocks to RPG Life Sciences

RPG Life Sciences FAQs

RPG Life Sciences share price is ₹2,119 As on 28 December, 2024 | 00:50

The Market Cap of RPG Life Sciences is ₹3505.6 Cr As on 28 December, 2024 | 00:50

The P/E ratio of RPG Life Sciences is 49.6 As on 28 December, 2024 | 00:50

The PB ratio of RPG Life Sciences is 9.4 As on 28 December, 2024 | 00:50

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23